Media coverage
1
Media coverage
Title FDA: Roflumilast Foam NDA Accepted for Seborrheic Dermatitis Media name/outlet Drug Topics (MJH) Country/Territory United States Date 1/04/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=6827-MFH1-JCXN-V387-00000-00 Persons Peter Lio